This content was funded by Boehringer Ingelheim, who had no influence or involvement in the development of the content. This material is intended for U.S. healthcare professionals.
Pulmonary fibrosis remains one of the most challenging respiratory diseases – often underdiagnosed, undertreated, and misunderstood. In this AMJ podcast, Ayodeji Adegunsoye and Toby Maher share their expert perspectives on how the field is changing, how recent data are shaping clinical decision-making, and why holistic, patient-centered care is critical.
To make the discussion easy to explore, the full episode has been divided into five mini-episodes, each tackling a critical aspect of pulmonary fibrosis care:
- A Decade Without New Options – Reflecting on the longstanding challenges and unmet needs in pulmonary fibrosis.
- Understanding the Latest Clinical Trial Data – Insights from the FIBRONEER program and what they mean for patients.
- From Hesitancy to Action: Reaching the Community Clinician – Overcoming inertia and improving treatment decisions.
- Psychosocial Support and Patient-Centered Care – Addressing mental health, caregiver strain, and quality-of-life needs.
- The Role of Primary Care in ILD Diagnosis – Why early recognition matters and how primary care providers can make a difference.
Watch the full podcast, or choose the mini-episodes most relevant to your practice, and hear expert perspectives on the evolving landscape of pulmonary fibrosis.
Speakers
Ayodeji Adegunsoye, MD, PhD 1
Toby Maher, MD, PhD 2
1. Assistant Professor of Medicine, Biological Sciences Division, University of Chicago, Illinois, USA
2. Professor of Clinical Medicine, Keck School of Medicine, University of Southern California, USA
